Opportunity Information: Apply for PAR 23 274

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
  • This funding opportunity was created on 2023-08-23.
  • Applicants must submit their applications by 2026-11-19.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 23 274

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: OJJDP FY 2023 Invited to Apply - Juvenile Justice Facility Leadership Certificate Program Training and Technical Assistance

Previous opportunity: USAID Nepali Women in Business

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 23 274

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 23 274) also looked into and applied for these:

Funding Opportunity
Chimeric Antigen Receptor (CAR) Approaches to AD/ADRD (R61/R33 Clinical Trial Not Allowed) Apply for RFA AG 24 046

Funding Number: RFA AG 24 046
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R34 Clinical Trial Optional) Apply for RFA MH 24 162

Funding Number: RFA MH 24 162
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Building Neuroscience Research Infrastructure for Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) in Africa (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA AG 24 027

Funding Number: RFA AG 24 027
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Community Partnerships to Advance Science for Society (ComPASS): Health Equity Research Hubs (UC2 Clinical Trial Optional) Apply for RFA RM 23 012

Funding Number: RFA RM 23 012
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Broadening Opportunities for Computational Genomics and Data Science Education (UE5 Clinical Trial Not Allowed) Apply for RFA HG 23 002

Funding Number: RFA HG 23 002
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care (R01 Clinical Trial Optional) Apply for RFA AG 24 031

Funding Number: RFA AG 24 031
Agency: National Institutes of Health
Category: Health
Funding Amount: $400,000
Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care Coordinating Center (U54 Clinical Trial Optional) Apply for RFA AG 24 030

Funding Number: RFA AG 24 030
Agency: National Institutes of Health
Category: Health
Funding Amount: $2,750,000
Collaborative Science to Achieve Disruptive Innovations in Dental, Oral and Craniofacial (DOC) Research (RM1 Clinical Trial Not Allowed) Apply for RFA DE 24 003

Funding Number: RFA DE 24 003
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000
Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25 Clinical Trials Not Allowed) Apply for PAR 22 268

Funding Number: PAR 22 268
Agency: National Institutes of Health
Category: Health
Funding Amount: $325,000
Research Tools for Difficult to Culture Eukaryotic Pathogens (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 23 055

Funding Number: RFA AI 23 055
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Developing Salivary Components as Therapeutics for Oral Health (R01 Clinical Trial Not Allowed) Apply for RFA DE 24 004

Funding Number: RFA DE 24 004
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Developing Salivary Components as Therapeutics for Oral Health (R21 Clinical Trial Not Allowed) Apply for RFA DE 24 005

Funding Number: RFA DE 24 005
Agency: National Institutes of Health
Category: Health
Funding Amount: $275,000
Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Assay and Data Generation Centers (RM1 Clinical Trial Not Allowed) Apply for RFA MH 25 145

Funding Number: RFA MH 25 145
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
IDeA Clinical and Translational Research Network (CTR-N) Award (P50 - Clinical Trial Optional) Apply for PAR 23 241

Funding Number: PAR 23 241
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,300,000
IDeA Clinical and Translational Research Development (CTR-D) Award (P20-Clinical Trial Optional) Apply for PAR 23 257

Funding Number: PAR 23 257
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,500,000
Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Youth from Underserved Populations (R34 Clinical Trial Optional) Apply for RFA MH 25 125

Funding Number: RFA MH 25 125
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Youth from Underserved Populations (R01 Clinical Trial Optional) Apply for RFA MH 25 126

Funding Number: RFA MH 25 126
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Human Tissue Core (U01- Clinical Trial Not Allowed) Apply for RFA HL 24 015

Funding Number: RFA HL 24 015
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Data Coordinating Center (U24- Clinical Trial Not Allowed) Apply for RFA HL 24 016

Funding Number: RFA HL 24 016
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,260,000
High-Priority Behavioral and Social Research Networks??(R24 Clinical Trial Optional) Apply for RFA AG 24 034

Funding Number: RFA AG 24 034
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 23 274", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: